A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency
Genotoxic drugs constitute a major treatment modality for human cancers; however, cancer cells' intrinsic DNA repair capability often increases the threshold of lethality and renders these drugs ineffective. The emerging roles of HDACs in DNA repair provide new opportunities for improving tradi...
Main Authors: | , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
Wiley Blackwell
2015
|
Online Access: | http://hdl.handle.net/1721.1/97593 |